Crossmark

[Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk

Crossref DOI link: https://doi.org/10.1016/j.ad.2022.01.040

Published Print: 2022-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carrascosa, J.M. http://orcid.org/0000-0003-4266-0771
Puig, L. http://orcid.org/0000-0001-6083-0952
Romero, I.B. http://orcid.org/0000-0002-6007-7320
Salgado-Boquete, L. http://orcid.org/0000-0002-0114-5469
del Alcázar, E. http://orcid.org/0000-0002-5935-356X
Lencina, J.J.A. http://orcid.org/0000-0002-0772-4752
Moreno, D. http://orcid.org/0000-0002-1301-7974
de la Cueva, P. http://orcid.org/0000-0003-4807-3551
License Information

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-05-21
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2022.01.040

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2022.01.024

Content Type: article

Copyright: © 2022 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below